The Global Insomnia Therapeutics Drugs Market is estimated to be US$ 3.6 Billion in 2023. It is poised to register 5.8% growth over the forecast period from 2023 to 2030 to reach US $ 5.3 billion 2030.
The market growth is driven by the increasing awareness of the adverse effects of chronic insomnia on overall health and quality of life has prompted more individuals to seek medical treatment, thereby driving the market. Leading companies are focusing on Innovative Drug Development, Biological and Genetic Approaches, Digital Health Solutions, Mental Health Awareness, Natural and Herbal Remedies, and others to boost market shares in the industry.
The Insomnia Therapeutics Drugs Market, influenced by factors such as the increasing prevalence of insomnia and aging populations, consists of major pharmaceutical companies offering prescription drugs, OTC medications, and non-pharmacological treatments. Challenges include potential side effects and competition from OTC and herbal remedies. The future outlook involves growth driven by personalized medicine, digital health solutions, and holistic treatments, with regional variations shaping market dynamics.
In the Insomnia Therapeutics Drugs Market, new drug classes and mechanisms of action include orexin receptor antagonists, dual orexin receptor antagonists, and novel GABAergic compounds. These innovations aim to target the orexin and GABA systems, offering potential for more effective and safer treatments for insomnia by modulating sleep-regulating pathways.
The demand for insomnia therapeutics drugs is boosted by the increasing use of telemedicine and remote healthcare services, which enable easier access to healthcare professionals and prescriptions for insomnia drugs without in-person visits. Telemedicine's expansion, particularly accelerated by the COVID-19 pandemic, has heightened the need for insomnia treatments as patients seek remote solutions for sleep disturbances. This trend contributes to the growth of the Insomnia Therapeutics Drugs Market.
Technological advancements, including wearable devices, smartphone apps, and telehealth platforms, are reshaping the Insomnia Therapeutics Drugs Market. These innovations enable sleep monitoring, personalized insights, and remote access to healthcare professionals, enhancing the management of insomnia. Digital therapeutics, such as CBT-I, are also gaining prominence, improving patient engagement and contributing to market growth.
The Global Insomnia Therapeutics Drugs Market is analyzed by Orexin antagonists, Benzodiazepines, Nonbenzodiazepines, Antidepressants, and others. Of these Orexin antagonists will register the fastest growth. Orexin antagonists are a promising addition to the Insomnia Therapeutics Drugs Market, targeting the orexin system to promote sleep by blocking orexin receptors. This novel mechanism of action offers effective and targeted treatments for insomnia, enhancing the range of options available in the market.
The Global Insomnia Therapeutics Drugs Market is analyzed across various Sales channels including Prescription, Over-the-counter (OTC), and Others. Of these Prescription held a significant market share in 2023. Prescription drugs are pivotal in the Insomnia Therapeutics Drugs Market, prescribed by healthcare professionals to treat insomnia and related sleep disorders. They encompass various categories, including sedative-hypnotics, benzodiazepines, non-benzodiazepines, and orexin receptor antagonists, aiming to help individuals initiate and maintain sleep and enhance sleep quality. These medications are a crucial component of the market, addressing diverse patient needs while requiring medical oversight and potentially having associated side effects.
By Drug Type
By Sales channel
By Region
· North America (United States, Canada, Mexico)
· Europe (Germany, France, United Kingdom, Spain, Italy, Others)
· Asia Pacific (China, India, Japan, South Korea, Australia, Others)
· Latin America (Brazil, Argentina, Others)
· Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)
* List not exhaustive
Insomnia Therapeutics Drugs Market Outlook 2023
1 Market Overview
1.1 Introduction to the Insomnia Therapeutics Drugs Market
1.2 Scope of the Study
1.3 Research Objective
1.3.1 Key Market Scope and Segments
1.3.2 Players Covered
1.3.3 Years Considered
2 Executive Summary
2.1 2023 Insomnia Therapeutics Drugs Industry- Market Statistics
3 Market Dynamics
3.1 Market Drivers
3.2 Market Challenges
3.3 Market Opportunities
3.4 Market Trends
4 Market Factor Analysis
4.1 Porter’s Five Forces
4.2 Market Entropy
4.2.1 Global Insomnia Therapeutics Drugs Market Companies with Area Served
4.2.2 Products Offerings Global Insomnia Therapeutics Drugs Market
5 COVID-19 Impact Analysis and Outlook Scenarios
5.1.1 Covid-19 Impact Analysis
5.1.2 post-COVID-19 Scenario- Low Growth Case
5.1.3 post-COVID-19 Scenario- Reference Growth Case
5.1.4 post-COVID-19 Scenario- Low Growth Case
6 Global Insomnia Therapeutics Drugs Market Trends
6.1 Global Insomnia Therapeutics Drugs Revenue (USD Million) and CAGR (%) by Type (2018-2030)
6.2 Global Insomnia Therapeutics Drugs Revenue (USD Million) and CAGR (%) by Applications (2018-2030)
6.3 Global Insomnia Therapeutics Drugs Revenue (USD Million) and CAGR (%) by regions (2018-2030)
7 Global Insomnia Therapeutics Drugs Market Revenue (USD Million) by Type, and Applications (2018-2022)
7.1 Global Insomnia Therapeutics Drugs Revenue (USD Million) by Type (2018-2022)
7.1.1 Global Insomnia Therapeutics Drugs Revenue (USD Million), Market Share (%) by Type (2018-2022)
7.2 Global Insomnia Therapeutics Drugs Revenue (USD Million) by Applications (2018-2022)
7.2.1 Global Insomnia Therapeutics Drugs Revenue (USD Million), Market Share (%) by Applications (2018-2022)
8 Global Insomnia Therapeutics Drugs Development Regional Status and Outlook
8.1 Global Insomnia Therapeutics Drugs Revenue (USD Million) By Regions (2018-2022)
8.2 North America Insomnia Therapeutics Drugs Revenue (USD Million) by Type, and Application (2018-2022)
8.2.1 North America Insomnia Therapeutics Drugs Revenue (USD Million) by Country (2018-2022)
8.2.2 North America Insomnia Therapeutics Drugs Revenue (USD Million) by Type (2018-2022)
8.2.3 North America Insomnia Therapeutics Drugs Revenue (USD Million) by Applications (2018-2022)
8.3 Europe Insomnia Therapeutics Drugs Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)
8.3.1 Europe Insomnia Therapeutics Drugs Revenue (USD Million), by Country (2018-2022)
8.3.2 Europe Insomnia Therapeutics Drugs Revenue (USD Million) by Type (2018-2022)
8.3.3 Europe Insomnia Therapeutics Drugs Revenue (USD Million) by Applications (2018-2022)
8.4 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)
8.4.1 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million) by Country (2018-2022)
8.4.2 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million) by Type (2018-2022)
8.4.3 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million) by Applications (2018-2022)
8.5 South America Insomnia Therapeutics Drugs Revenue (USD Million), by Type, and Applications (2018-2022)
8.5.1 South America Insomnia Therapeutics Drugs Revenue (USD Million), by Country (2018-2022)
8.5.2 South America Insomnia Therapeutics Drugs Revenue (USD Million) by Type (2018-2022)
8.5.3 South America Insomnia Therapeutics Drugs Revenue (USD Million) by Applications (2018-2022)
8.6 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)
8.6.1 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) by Country (2018-2022)
8.6.2 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) by Type (2018-2022)
8.6.3 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) by Applications (2018-2022)
9 Company Profiles
10 Global Insomnia Therapeutics Drugs Market Revenue (USD Million), by Type, and Applications (2023-2030)
10.1 Global Insomnia Therapeutics Drugs Revenue (USD Million) and Market Share (%) by Type (2023-2030)
10.1.1 Global Insomnia Therapeutics Drugs Revenue (USD Million), and Market Share (%) by Type (2023-2030)
10.2 Global Insomnia Therapeutics Drugs Revenue (USD Million) and Market Share (%) by Applications (2023-2030)
10.2.1 Global Insomnia Therapeutics Drugs Revenue (USD Million), and Market Share (%) by Applications (2023-2030)
11 Global Insomnia Therapeutics Drugs Development Regional Status and Outlook Forecast
11.1 Global Insomnia Therapeutics Drugs Revenue (USD Million) By Regions (2023-2030)
11.2 North America Insomnia Therapeutics Drugs Revenue (USD Million) by Type, and Applications (2023-2030)
11.2.1 North America Insomnia Therapeutics Drugs Revenue (USD) Million by Country (2023-2030)
11.2.2 North America Insomnia Therapeutics Drugs Revenue (USD Million), by Type (2023-2030)
11.2.3 North America Insomnia Therapeutics Drugs Revenue (USD Million), Market Share (%) by Applications (2023-2030)
11.3 Europe Insomnia Therapeutics Drugs Revenue (USD Million), by Type, and Applications (2023-2030)
11.3.1 Europe Insomnia Therapeutics Drugs Revenue (USD Million), by Country (2023-2030)
11.3.2 Europe Insomnia Therapeutics Drugs Revenue (USD Million), by Type (2023-2030)
11.3.3 Europe Insomnia Therapeutics Drugs Revenue (USD Million), by Applications (2023-2030)
11.4 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million) by Type, and Applications (2023-2030)
11.4.1 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million), by Country (2023-2030)
11.4.2 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million), by Type (2023-2030)
11.4.3 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million), by Applications (2023-2030)
11.5 South America Insomnia Therapeutics Drugs Revenue (USD Million), by Type, and Applications (2023-2030)
11.5.1 South America Insomnia Therapeutics Drugs Revenue (USD Million), by Country (2023-2030)
11.5.2 South America Insomnia Therapeutics Drugs Revenue (USD Million), by Type (2023-2030)
11.5.3 South America Insomnia Therapeutics Drugs Revenue (USD Million), by Applications (2023-2030)
11.6 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million), by Type, and Applications (2023-2030)
11.6.1 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million), by region (2023-2030)
11.6.2 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million), by Type (2023-2030)
11.6.3 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million), by Applications (2023-2030)
12 Methodology and Data Sources
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Sources
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Disclaimer
List of Tables
Table 1 Market Segmentation Analysis
Table 2 Global Insomnia Therapeutics Drugs Market Companies with Areas Served
Table 3 Products Offerings Global Insomnia Therapeutics Drugs Market
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Insomnia Therapeutics Drugs Revenue (USD Million) And CAGR (%) By Type (2018-2030)
Table 8 Global Insomnia Therapeutics Drugs Revenue (USD Million) And CAGR (%) By Applications (2018-2030)
Table 9 Global Insomnia Therapeutics Drugs Revenue (USD Million) And CAGR (%) By Regions (2018-2030)
Table 10 Global Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2018-2022)
Table 11 Global Insomnia Therapeutics Drugs Revenue Market Share (%) By Type (2018-2022)
Table 12 Global Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2018-2022)
Table 13 Global Insomnia Therapeutics Drugs Revenue Market Share (%) By Applications (2018-2022)
Table 14 Global Insomnia Therapeutics Drugs Market Revenue (USD Million) By Regions (2018-2022)
Table 15 Global Insomnia Therapeutics Drugs Market Share (%) By Regions (2018-2022)
Table 16 North America Insomnia Therapeutics Drugs Revenue (USD Million) By Country (2018-2022)
Table 17 North America Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2018-2022)
Table 18 North America Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2018-2022)
Table 19 Europe Insomnia Therapeutics Drugs Revenue (USD Million) By Country (2018-2022)
Table 20 Europe Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2018-2022)
Table 21 Europe Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2018-2022)
Table 22 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million) By Country (2018-2022)
Table 23 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2018-2022)
Table 24 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2018-2022)
Table 25 South America Insomnia Therapeutics Drugs Revenue (USD Million) By Country (2018-2022)
Table 26 South America Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2018-2022)
Table 27 South America Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2018-2022)
Table 28 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) By Region (2018-2022)
Table 29 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2018-2022)
Table 30 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2018-2022)
Table 31 Financial Analysis
Table 32 Global Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2023-2030)
Table 33 Global Insomnia Therapeutics Drugs Revenue Market Share (%) By Type (2023-2030)
Table 34 Global Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2023-2030)
Table 35 Global Insomnia Therapeutics Drugs Revenue Market Share (%) By Applications (2023-2030)
Table 36 Global Insomnia Therapeutics Drugs Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)
Table 37 North America Insomnia Therapeutics Drugs Revenue (USD)By Country (2023-2030)
Table 38 North America Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2023-2030)
Table 39 North America Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2023-2030)
Table 40 Europe Insomnia Therapeutics Drugs Revenue (USD Million) By Country (2023-2030)
Table 41 Europe Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2023-2030)
Table 42 Europe Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2023-2030)
Table 43 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million) By Country (2023-2030)
Table 44 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2023-2030)
Table 45 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2023-2030)
Table 46 South America Insomnia Therapeutics Drugs Revenue (USD Million) By Country (2023-2030)
Table 47 South America Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2023-2030)
Table 48 South America Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2023-2030)
Table 49 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) By Region (2023-2030)
Table 50 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) By Region (2023-2030)
Table 51 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2023-2030)
Table 52 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2023-2030)
Table 53 Research Programs/Design for This Report
Table 54 Key Data Information from Secondary Sources
Table 55 Key Data Information from Primary Sources
List of Figures
Figure 1 Market Scope
Figure 2 Porter’s Five Forces
Figure 3 Global Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2018-2022)
Figure 4 Global Insomnia Therapeutics Drugs Revenue Market Share (%) By Type (2022)
Figure 5 Global Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2018-2022)
Figure 6 Global Insomnia Therapeutics Drugs Revenue Market Share (%) By Applications (2022)
Figure 7 Global Insomnia Therapeutics Drugs Market Revenue (USD Million) By Regions (2018-2022)
Figure 8 Global Insomnia Therapeutics Drugs Market Share (%) By Regions (2022)
Figure 9 North America Insomnia Therapeutics Drugs Revenue (USD Million) By Country (2018-2022)
Figure 10 North America Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2018-2022)
Figure 11 North America Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2018-2022)
Figure 12 Europe Insomnia Therapeutics Drugs Revenue (USD Million) By Country (2018-2022)
Figure 13 Europe Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2018-2022)
Figure 14 Europe Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2018-2022)
Figure 15 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million) By Country (2018-2022)
Figure 16 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2018-2022)
Figure 17 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2018-2022)
Figure 18 South America Insomnia Therapeutics Drugs Revenue (USD Million) By Country (2018-2022)
Figure 19 South America Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2018-2022)
Figure 20 South America Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2018-2022)
Figure 21 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) By Region (2018-2022)
Figure 22 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2018-2022)
Figure 23 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2018-2022)
Figure 24 Global Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2023-2030)
Figure 25 Global Insomnia Therapeutics Drugs Revenue Market Share (%) By Type (2030)
Figure 26 Global Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2023-2030)
Figure 27 Global Insomnia Therapeutics Drugs Revenue Market Share (%) By Applications (2030)
Figure 28 Global Insomnia Therapeutics Drugs Market Revenue (USD Million) By Regions (2023-2030)
Figure 29 North America Insomnia Therapeutics Drugs Revenue (USD Million) By Country (2023-2030)
Figure 30 North America Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2023-2030)
Figure 31 North America Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2023-2030)
Figure 32 Europe Insomnia Therapeutics Drugs Revenue (USD Million) By Country (2023-2030)
Figure 33 Europe Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2023-2030)
Figure 34 Europe Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2023-2030)
Figure 35 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million) By Country (2023-2030)
Figure 36 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2023-2030)
Figure 37 Asia Pacific Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2023-2030)
Figure 38 South America Insomnia Therapeutics Drugs Revenue (USD Million) By Country (2023-2030)
Figure 39 South America Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2023-2030)
Figure 40 South America Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2023-2030)
Figure 41 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) By Region (2023-2030)
Figure 42 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) By Region (2023-2030)
Figure 43 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) By Type (2023-2030)
Figure 44 Middle East and Africa Insomnia Therapeutics Drugs Revenue (USD Million) By Applications (2023-2030)
Figure 45 Bottom-Up and Top-Down Approaches for This Report
Figure 46 Data Triangulation
By Drug Type
By Sales channel